Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.05.2014 | review

Follow-up in non-small-cell lung cancer

verfasst von: Sacha I. Rothschild, MD, PhD, Didier Lardinois, MD, Jens Bremerich, MD, Michael Tamm, MD, Lukas Bubendorf, MD, Alexandros Papachristofilou, MD, Hansruedi Stoll, MSc, Alfred Zippelius, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The major impetus for structured follow-up after primary treatment of localized non-small-cell lung cancer is both early detection and re-treatment of recurrent disease with a curative intent, and early detection and treatment of a secondary primary tumor. In patients with lung cancer, the significance of intensive follow-up is still under debate.
Vorheriger Artikel Follow-up in soft tissue sarcomas
Nächster Artikel Follow-up in gastrointestinal cancer
Literatur
1.
2.
Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111(6):1710–7.PubMedCrossRef
3.
Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109(1):120–9.PubMedCrossRef
4.
al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg. 1997;12:380–4.PubMedCrossRef
5.
Martin J, Ginsberg RJ, Venkatraman ES, Bains MS, Downey RJ, Korst RJ, Kris MG, Rusch VW. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol. 2002;20:1989–95.PubMedCrossRef
6.
The Ludwig Lung Cancer Study Group. Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg. 1987;205(1):67–71.CrossRef
7.
Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, Williams BA, Pairolero PC. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83(2):409–17. Discussion 417–8.PubMedCrossRef
8.
Thomas P, Rubinstein L. Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1990;49:242–7.PubMedCrossRef
9.
Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998;90:1335–45.PubMedCrossRef
10.
Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg. 1990;99:769–77. Discussion 777–8.PubMed
11.
Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606–12.PubMed
12.
Edelman MJ, Schuetz J. Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resection. Curr Treat Options Oncol. 2002;3(1)67–73.PubMedCrossRef
13.
Naunheim KS, Virgo KS, Coplin MA, Johnson FE. Clinical surveillance testing after lung cancer operations. Ann Thorac Surg. 1995;60(6):1612–6.PubMedCrossRef
14.
Virgo KS, Naunheim KS, Coplin MA, Johnson FE. Lung cancer patient follow-up: motivation of thoracic surgeons. Chest. 1998;114:1519–34.PubMedCrossRef
15.
Colice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest. 2003;123:272S–83S.PubMedCrossRef
16.
Vansteenkiste J, Crino L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, Rocco G, Senan S, Van Schil P, Veronesi G, Stahel R, Peters S, Felip E. 2nd ESMO Consensus Conference on Lung Cancer: early stage non-small cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. In press 2014.
17.
Colt HG, Murgu SD, Korst RJ, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e437S–54S.PubMedCrossRef
18.
19.
20.
Moore S, Corner J, Haviland J, Wells M, Salmon E, Normand C, Brada M, O’Brien M, Smith I. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ. 2002;325(7373):1145.PubMedCentralPubMedCrossRef
21.
Virgo KS, McKirgan LW, Caputo MC, Mahurin DM, Chao LC, Caputo NA, Naunheim KS, Flye MW, Gillespie KN, Johnson FE. Post-treatment management options for patients with lung cancer. Ann Surg. 1995;222(6):700–10.PubMedCentralPubMedCrossRef
22.
Nakamura R, Kurishima K, Kobayashi N, Ishikawa S, Goto Y, Sakai M, Onizuka M, Ishikawa H, Satoh H, Hizawa N, Sato Y. Postoperative follow-up for patients with non-small cell lung cancer. Onkologie. 2010;33(1–2):14–8.PubMed
23.
Younes RN, Gross JL. Follow-up in lung cancer how often and for what purpose? Chest. 1999;115:1494–9.PubMedCrossRef
24.
Egermann U, Jaeggi K, Habicht JM, Perruchoud AP, Dalquen P, Soler M. Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Eur Respir J. 2002;19(3):464–8.PubMedCrossRef
25.
Walsh GL, O’Connor M, Willis KM, Milas M, Wong RS, Nesbitt JC, Putnam JB, Lee JJ, Roth JA. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg. 1995;60(6):1563–70. Discussion 1570–2.PubMedCrossRef
26.
Westeel V, Choma D, Clément F, Woronoff-Lemsi MC, Pugin JF, Dubiez A, Depierre A. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg. 2000;70:1185–90.PubMedCrossRef
27.
Song IH, Yeom SW, Heo S, Choi WS, Yang HC, Jheon S, Kim K, Cho S. Prognostic factors for post-recurrence survival in patients with completely resected stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(2):262–7.PubMedCrossRef
28.
Curran WJ, Herbert SH, Stafford PM, Sandler HM, Rosenthal SA, McKenna WG, Hughes E, Dougherty MJ, Keller S. Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy? Int J Radiat Oncol Biol Phys. 1992;24:25–30.PubMedCrossRef
29.
30.
Hanna WC, Paul NS, Darling GE, Moshonov H, Allison F, Waddell TK, Cypel M, de Perrot ME, Yasufuku K, Keshavjee S, Pierre AF. Minimal-dose computed tomography is superior to chest x-ray for the follow-up and treatment of patients with resected lung cancer. J Thorac Cardiovasc Surg. 2014;147(1):30–3.PubMedCrossRef
31.
Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.PubMedCrossRef
32.
Weber W, Young C, Abdel-Dayem HM, Sfakianakis G, Weir GJ, Swaney CM, Gates M, Stokkel MP, Parker A, Hines H, Khanvali B, Liebig JR, Leung AN, Sollitto R, Caputo G, Wagner HN. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. J Nucl Med. 1999;40(4):574–8.PubMed
33.
Monteil J, Vergnenègre A, Bertin F, Dalmay F, Gaillard S, Bonnaud F, Melloni B. Randomized follow-up study of resected NSCLC patients: conventional versus 18F-DG coincidence imaging. Anticancer Res. 2010;30(9):3811–6.PubMed
34.
Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132(2):401–10.PubMedCrossRef
35.
Park SM, Lim MK, Jung KW, Shin SA, Yoo K-Y, Yun YH, Huh BY. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National health insurance corporation study. J Clin Oncol. 2007;25(30):4835–43.PubMedCrossRef
36.
Gajdos C, Hawn MT, Campagna EJ, Henderson WG, Singh JA, Houston T. Adverse effects of smoking on postoperative outcomes in cancer patients. Ann Surg Oncol. 2012;19(5):1430–8.PubMedCrossRef
37.
Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569.PubMedCentralPubMedCrossRef
Metadaten
Titel
Follow-up in non-small-cell lung cancer
verfasst von
Sacha I. Rothschild, MD, PhD
Didier Lardinois, MD
Jens Bremerich, MD
Michael Tamm, MD
Lukas Bubendorf, MD
Alexandros Papachristofilou, MD
Hansruedi Stoll, MSc
Alfred Zippelius, MD
Publikationsdatum
01.05.2014
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2014
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-014-0144-x

Weitere Artikel der Ausgabe 2/2014

Follow-up for patients with malignancies after radical treatment: unresolved questions

  • editorial

Follow-up in gastrointestinal cancer

  • short review

Follow-up in soft tissue sarcomas

  • Open Access
  • short review

Highlights in the prevention of sporadic colorectal cancer

  • short review

Follow-up in aggressive lymphomas

  • short review

An academic pathological dilemma

  • editorial